Skip to main content
FinSpry Logo
FinSpry
BIIB logo
BIIB
(NASDAQ)
Biogen Inc.
$200.62-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Biogen Inc. (BIIB) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Biogen Inc. stock.

Analyst Consensus Rating

Investment consensus from 34 professional research analysts

Consensus Rating

Buy
Based on 34 unique analysts
(51 total ratings in last 90 days)
Very High Confidence11.0:1 Buy/Sell

Average Price Target

$224.04
↑ 11.67% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest BIIB Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Sumant Kulkarni
Canaccord Genuity
BuyReiterates
$245.00
David Amsellem
Piper Sandler
BuyReiterates
$225.00
Thomas Shrader
BTIG
HoldMaintains
-
Salveen Richter
Goldman Sachs
BuyMaintains
$250.00
Geoff Meacham
Citi
HoldMaintains
$200.00
Zacks Equity Research
Zacks Equity Research
SellInitiates Coverage
-
Laura Chico
Wedbush
HoldReiterates
$196.00 → $201.00
Andrew Tsai
Jefferies
BuyMaintains
$255.00
Evan Seigerman
BMO Capital
HoldMaintains
$196.00
Jasper Hellweg
Argus Research
HoldMaintains
-
Jason Zemansky
BofA Securities
HoldReiterates
$203.00 → $217.00
Terence Flynn
Morgan Stanley
HoldMaintains
$224.00 → $222.00
Andrew Tsai
Jefferies
BuyMaintains
$255.00
Brian Abrahams
RBC Capital
BuyMaintains
$227.00 → $242.00
Morten Herholdt
HSBC
SellMaintains
$150.00 → $157.00
Ananda Ghosh
HC Wainwright
BuyMaintains
$228.00 → $237.00
Andrew Fein
HC Wainwright
BuyMaintains
$228.00 → $237.00
Ami Fadia
Needham
BuyReiterates
$255.00 → $256.00
Michael Yee
UBS
BuyMaintains
$225.00
Michael Yee
UBS
BuyMaintains
$225.00
Eric Schmidt FCA
Cantor Fitzgerald
BuyInitiates
$206.00
Ami Fadia
Needham
BuyUpgrades
-
Salim Syed
Mizuho
BuyReiterates
$236.00 → $221.00
Google Drug Manufacturers - General
TipRanks - Google
BuyReiterates
$232.00 → $225.00
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
BuyReiterates
$239.00 → $228.00
Anthropic Drug Manufacturers - General
TipRanks - Anthropic
HoldReiterates
$210.00 → $204.00
DeepSeek Drug Manufacturers - General
TipRanks - DeepSeek
BuyReiterates
$231.00 → $221.00
xAi Drug Manufacturers - General
TipRanks - xAI
BuyReiterates
$229.00 → $226.00
OpenAI Drug Manufacturers - General
TipRanks - OpenAI
BuyReiterates
$229.00 → $222.00
David Amsellem
Piper Sandler
BuyReiterates
$225.00
Brian Abrahams
RBC Capital
BuyMaintains
$222.00 → $227.00
Myles Minter
William Blair
BuyMaintains
-
Mohit Bansal
Wells Fargo
BuyMaintains
$250.00
Laura Chico
Wedbush
HoldMaintains
$196.00
Sumant Kulkarni
Canaccord Genuity
BuyReiterates
$245.00
Danielle Brill
Truist
HoldMaintains
-
Salveen Richter
Goldman Sachs
BuyMaintains
$238.00 → $250.00
Michael Yee
UBS
BuyReiterates
$225.00
Umer Raffat
Evercore ISI Group
BuyInitiates
-
Andrew Fein
HC Wainwright
BuyMaintains
$237.00
Phil Nadeau
TD Cowen
BuyMaintains
$215.00
Emily Field
Barclays
HoldReiterates
$185.00
Jason Zemansky
BofA Securities
HoldMaintains
$203.00
Evan Seigerman
BMO Capital
HoldMaintains
$196.00
Terence Flynn
Morgan Stanley
HoldMaintains
$206.00
Geoff Meacham
Citi
HoldInitiates Coverage
$190.00 → $200.00
Ilya Zubkov
Freedom Capital
BuyDowngrades
$185.00 → $245.00
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
BuyReiterates
$205.00 → $202.00
Yatin Suneja
Guggenheim
BuyReiterates
$246.00 → $260.00
Sumant Kulkarni
Canaccord Genuity
BuyReiterates
$245.00
Danielle Brill
Truist
HoldMaintains
-

Frequently Asked Questions

What is the analyst consensus rating for BIIB?

The analyst consensus rating for BIIB is "Buy" based on 34 analyst recommendations.

What is the average price target for BIIB?

The average 12-month price target for BIIB is $224.04, representing an upside of 11.7% from the current price of $200.62.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.